1. The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men;Agersø;Diabetologia,2002
2. Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice;Ahren;Am J Physiol,1999
3. SAAM II: simulation, analysis, and modeling software for tracer and pharmacokinetic studies;Barrett;Metabolism,1998
4. NONMEM Users Guide;Beal,2000
5. Quantitative estimation of insulin sensitivity;Bergman;Am. J. Physiol.,1979